Click here to Register

2017 Executive Sponsors

BD Medical

2017 Associate Sponsors

Insulet Corporation
iO Lifescience
Pfizer Inc

2017 Technology Sponsors

Cambridge Design Partnership
Credence medsystems
Cristal Therapeutics
DALI Medical Devices
DS Technology GmbH
Enable Injections
InnoCore Pharmaceuticals
leon nanodrugs
Mitsubishi Gas Chemical
Oakwood Labs
Phion Therapeutics Limited
Portal Instruments
pSivida Corp
Quantex Vernay
Serina Therapeutics
West Pharmaceutical Services
Windgap Medical

2017 Exhibitors

Baumann Group
Maxon Motor
Mikron Corporation Denver
NN Inc Precision Engineered Products
Stress Engineering Services
Team Consulting
Terumo Pharmaceutical Solutions

2017 Soapbox Sponsors

Cocoon Biotech
Sonoran Biosciences

2017 Media Partners

Drug Development and Delivery
MCD Group, LLC
Med Device Online
Pharmaceutical Online
SciDoc Publishers
Technology Networks


An Insight into PODD


Our 7th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 19-20, 2017 at the Marriott Copley Place in Boston.

This annual Boston-based conference is designed with three purposes:

PODD Audience Web

  1. To present a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
  2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
  3. To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.

The 7th annual event will be chaired by Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche. New to PODD this year, keynoting is Dr Jeffrey Karp, a bioengineer and world leader in drug delivery, stem cell therapeutics, and tissue adhesives. We are also delighted to welcome two additional keynote speakers: Lars Rebien Sorensen, former President and CEO of Novo Nordisk and Dr Omid Farokhzad, Associate Professor at Harvard Medical School and Director of the Center for Nanomedicine at BWH.

Our distinguished speaking faculty also includes the following Technology Track Chairs: Justin Wright, PhD, VP, Drug Delivery Innovation, DDR&D Technology at Eli Lilly; Mathias Romacker, Senior Director, Device Strategy at Pfizer; Matthew Burke, PhD, Head of Drug Delivery at GSK; Rene Holm, PhD, Head and Scientific Director, Drug Product Development, Liquids and Parenterals at Janssen; and Robert Saklatvala, PhD, Director, Discovery Pharmaceutical Sciences at Merck.

Please contact us at if you have any questions. Registration is open and take advantage of the earliest rates.


Valerie Bowling New



Valerie Bowling
Executive Director

Michelle McDermott B&W



Michelle McDermott
Conference Producer


Meredith Sands
Executive Director, Business Development


  • "Excellent PODD conference."

    - James Spavins, Pfizer

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "I found the conference very insightful and the one-to-one meetings highly valuable.  Congratulations on organizing a wonderful conference!"

    - Mary Gardner, Hospira Inc.

  • "We were impressed by the size of the turn out, the caliber of the individuals in attendance and the quality of the panels, presentations and discussions. It was a pleasure and privilege for us to attend. We only hope that our presence added to your conference as much as your conference added to our position in the pharma community. The conference team consistently got "right" both the technicalities, as well as the personalities.  Great job, well done. Congratulations, and kudos, to all of you."

    - Susan Rosenbaum, Lauren Sciences LLC

  • "A nice and fruitful meeting."

    - Sylvestre Grizot, PhD, MedinCell S.A.

  • "I enjoyed the opportunity and the new connections I made.  I look forward to next year’s event."

    - Jonathan Behr, PhD, Partners Healthcare

  • " Very much enjoyed both the 1st and 2nd PODD meetings - and looking forward to the 3rd in Boston next year. Great forum for anyone interested in drug delivery for the biopharma industry"

    - Baruch Harris, PhD, Forum Pharmaceuticals

  • "Overall, outstanding conference, well done!"

    - Ralph Solarski, PhD, Kimberly-Clark Corporation

  • "Congratulations on a very successful conference! It is a very unique conference and I enjoyed it very much."

    - Avinash G. Thombre, PhD, Pfizer Inc.

  • "Great conference!"

    - Jones W. Bryan, PhD, Supernus Pharmaceuticals

  • "Thank you for a great conference that brought us together to network and share ideas. The conference is refreshing and well organized. Congratulations for a job well done."

    - Peter Hoffmann, PhD, ph Associates

  • "I enjoyed the panels and the meeting was well done."

    - Jack Talley, EpiCept Corp.

  • "Nice job!! Thanks to the conference organizers."

    - Jonathan M. Rigby, SteadyMed Therapeutics, Inc.

  • "Thank you for an excellent conference."

    - Jane Nichols, MBA, Nanocopoeia Inc.

  • "I enjoyed the conference and received a number of interesting leads from it."

    - Julius Knowles, Novartis Institutes for BioMedical Research, Inc.

  • "I was honestly very much impressed by the conference, the set up with presentations and panels and the high level number of executives from the different stakeholders."

    - Sven Stegemann, PhD, Geriatric Medicine Society

  • "It was a great event and my thanks to you and your excellent team."

    - Keith Horspool, PhD, Boehringer Ingelheim

  • "It was a great pleasure to attend PODD.  Thank for organizing this meeting."

    - Ye (Bill) Huang, PhD, Global Pharmaceutical Science

  • "I thoroughly enjoyed the conference, the meetings and the presentations."

    - Monica Fernand, BD Medical – Pharmaceutical Systems